Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation von Yan, L, Zhou, J, Gao, Y, Ghazal, S, Lu, L, Bellone, S, Yang, Y, Liu, N, Zhao, X, Santin, A D, Taylor, H, Huang, Y

Volltext

In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma von El-Sahwi, K, Bellone, S, Cocco, E, Cargnelutti, M, Casagrande, F, Bellone, M, Abu-Khalaf, M, Buza, N, Tavassoli, F A, Hui, P, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D

Volltext

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study von Matulonis, U.A., Shapira-Frommer, R., Santin, A.D., Lisyanskaya, A.S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G.S., Birrer, M., Provencher, D.M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P.B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J., Ledermann, J.A.

Volltext

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytoto... von Bellone, S, Roque, D, Cocco, E, Gasparrini, S, Bortolomai, I, Buza, N, Abu-Khalaf, M, Silasi, D-A, Ratner, E, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D

Volltext

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket tria... von Bardia, A., Messersmith, W.A., Kio, E.A., Berlin, J.D., Vahdat, L., Masters, G.A., Moroose, R., Santin, A.D., Kalinsky, K., Picozzi, V., O'Shaughnessy, J., Gray, J.E., Komiya, T., Lang, J.M., Chang, J.C., Starodub, A., Goldenberg, D.M., Sharkey, R.M., Maliakal, P., Hong, Q., Wegener, W.A., Goswami, T., Ocean, A.J.

Volltext

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy von Santin, A D, Zhan, F, Cane', S, Bellone, S, Palmieri, M, Thomas, M, Burnett, A, Roman, J J, Cannon, M J, Shaughnessy, J, Pecorelli, S

Volltext

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy von Bellone, S, Tassi, R, Betti, M, English, D, Cocco, E, Gasparrini, S, Bortolomai, I, Black, J D, Todeschini, P, Romani, C, Ravaggi, A, Bignotti, E, Bandiera, E, Zanotti, L, Pecorelli, S, Ardighieri, L, Falchetti, M, Donzelli, C, Siegel, E R, Azodi, M, Silasi, D-A, Ratner, E, Schwartz, P E, Rutherford, T J, Santin, A D

Volltext

Her2 neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab von Todeschini, P, Cocco, E, Bellone, S, Varughese, J, Lin, K, Carrara, L, Guzzo, F, Buza, N, Hui, P, Silasi, D-A, Ratner, E, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D

Volltext

A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT... von Bellone, S., Roque, D.M., Siegel, E.R., Buza, N., Hui, P., Bonazzoli, E., Guglielmi, A., Zammataro, L., Nagarkatti, N., Zaidi, S., Lee, J., Silasi, D.-A., Huang, G.S., Andikyan, V., Damast, S., Clark, M., Azodi, M., Schwartz, P.E., Tymon-Rosario, J., Harold, J., Mauricio, D., Zeybek, B., Menderes, G., Altwerger, G., Ratner, E., Alexandrov, L.B., Iwasaki, A., Kong, Y., Song, E., Dong, W., Elvin, J., Choi, J., Santin, A.D.

Volltext

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas von Bignotti, E, Ravaggi, A, Tassi, R A, Calza, S, Rossi, E, Falchetti, M, Romani, C, Bandiera, E, Odicino, F E, Pecorelli, S, Santin, A D

Volltext

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 von Santin, A.D., Scheim, D.E., McCullough, P.A., Yagisawa, M., Borody, T.J.

Volltext

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling von Santin, A D, Zhan, F, Bellone, S, Palmieri, M, Cane, S, Gokden, M, Roman, J J, O'Brien, T J, Tian, E, Cannon, M J, Shaughnessy, J, Pecorelli, S

Volltext

GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase III trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in ≥ second-line recurren... von Tewari, K.S., Vergote, I., Oaknin, A., Alvarez, E., Gaillard, S., Lheureux, S., Rischin, D., Santin, A.D., Feng, M., Mathias, M., Fury, M., Lowy, I., Monk, B.J.

Volltext

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo von Schwab, C L, Bellone, S, English, D P, Roque, D M, Lopez, S, Cocco, E, Nicoletti, R, Bortolomai, I, Bonazzoli, E, Ratner, E, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Santin, A D

Volltext

Lymph node metastases : The importance of the microenvironment von SANTIN, A. D

Volltext

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients von Ravaggi, A, Romani, C, Pasinetti, B, Tassi, R. A, Bignotti, E, Bandiera, E, Odicino, F. E, Ragnoli, M, Donzelli, C, Falchetti, M, Calza, S, Santin, A. D, Pecorelli, S

Volltext

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer von Makker, Vicky, Colombo, Nicoletta, Casado Herráez, Antonio, Santin, Alessandro D, Colomba, Emeline, Miller, David S, Fujiwara, Keiichi, Pignata, Sandro, Baron-Hay, Sally, Ray-Coquard, Isabelle, Shapira-Frommer, Ronnie, Ushijima, Kimio, Sakata, Jun, Yonemori, Kan, Kim, Yong Man, Guerra, Eva M, Sanli, Ulus A, McCormack, Mary M, Smith, Alan D, Keefe, Stephen, Bird, Steven, Dutta, Lea, Orlowski, Robert J, Lorusso, Domenica

Volltext

Induction of tumour-specific CD8 cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer von Santin, A D, Bellone, S, Ravaggi, A, Roman, J J, Pecorelli, S, Parham, G P, Cannon, M J

Volltext

Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer von Lal-Nag, M, Battis, M, Santin, A D, Morin, P J

Volltext

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer von Cocco, E, Bellone, S, El-Sahwi, K, Cargnelutti, M, Casagrande, F, Buza, N, Tavassoli, F A, Siegel, E R, Visintin, I, Ratner, E, Silasi, D-A, Azodi, M, Schwartz, P E, Rutherford, T J, Pecorelli, S, Santin, A D

Volltext